Related Experiment Video

Updated: May 14, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Intelligent detection of hypoglycemic episodes in children with type 1 diabetes using adaptive neural-fuzzy inference

Phyo Phyo San1, Sai Ho Ling, Hung T Nguyen

  • 1Centre for Health Technologies, Faculty of Engineering and IT, University of Technology Sydney, Ultimo, NSW, Australia. PhyoPhyo.San@student.uts.edu.au

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
|February 1, 2013
PubMed

Insights

Hypoglycemia in Type 1 diabetes patients can be detected using an intelligent system analyzing heart rate and ECG signals. This method shows promise for recognizing low blood glucose complications.

Area of Science:

  • Biomedical Engineering
  • Artificial Intelligence in Medicine
  • Endocrinology

Background:

  • Hypoglycemia is a frequent and dangerous complication for Type 1 diabetes mellitus (T1DM) patients.
  • Physiological parameters like heart rate (HR) and corrected QT interval (QTc) from ECG signals are affected during hypoglycemic events.

Purpose of the Study:

  • To develop an intelligent diagnostic system for recognizing hypoglycemia in T1DM patients.
  • To utilize physiological parameters for hypoglycemia detection.

Main Methods:

  • An adaptive neural fuzzy inference system (ANFIS) was employed, combining adaptive neural networks and fuzzy inference.
  • A hybrid particle swarm optimization with wavelet mutation (HPSOWM) algorithm was used to optimize ANFIS parameters.
  • Clinical data from 15 children with T1DM was collected and analyzed using training, validation, and testing sets.

Main Results:

  • The proposed ANFIS system achieved a sensitivity of 79.09% for hypoglycemia detection.
  • An acceptable specificity of 51.82% was recorded.
  • The system demonstrated satisfactory effectiveness in recognizing hypoglycemic events.

Conclusions:

  • The intelligent diagnostic system using ANFIS shows potential for detecting hypoglycemia in T1DM patients.
  • The hybrid optimization approach (HPSOWM) effectively tuned the ANFIS model.
  • Further research may refine the system for improved diagnostic accuracy.

More Related Videos

Artificial Intelligence-Based System for Detecting Attention Levels in Students06:37

Artificial Intelligence-Based System for Detecting Attention Levels in Students

Published on: December 15, 2023

Related Concept Videos

Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...